MRZM
Price:
$0.04
Market Cap:
$5.27M
Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and burns, acute ischemic stroke, deep vein thrombosis, and dissolving plaque and biofilms on teeth. In addition, it focuses on developing products to mitigate the effects of ischemia reperfusion injury in other grafting and transplantation surgeries, and o...[Read more]
Industry
Biotechnology
IPO Date
2010-11-10
Stock Exchange
PNK
Ticker
MRZM
According to Marizyme, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 25.72M. This represents a change of -13.32% compared to the average of 29.67M of the last 4 quarters.
The mean historical Enterprise Value of Marizyme, Inc. over the last ten years is 20.09M. The current 25.72M Enterprise Value has changed 12.70% with respect to the historical average. Over the past ten years (40 quarters), MRZM's Enterprise Value was at its highest in in the June 2022 quarter at 110.53M. The Enterprise Value was at its lowest in in the December 2017 quarter at -31983.66.
Average
20.09M
Median
11.49M
Minimum
-31982.52
Maximum
64.35M
Discovering the peaks and valleys of Marizyme, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 550.25%
Maximum Annual Enterprise Value = 64.35M
Minimum Annual Increase = -39731.94%
Minimum Annual Enterprise Value = -31982.52
Year | Enterprise Value | Change |
---|---|---|
2023 | 23.12M | -12.58% |
2022 | 26.44M | -57.78% |
2021 | 62.64M | -2.66% |
2020 | 64.35M | 524.82% |
2019 | 10.30M | -18.75% |
2018 | 12.68M | -39731.94% |
2017 | -31982.52 | -132.85% |
2016 | 97.35K | -91.55% |
2015 | 1.15M | 550.25% |
2014 | 177.28K | -76.14% |
The current Enterprise Value of Marizyme, Inc. (MRZM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
37.40M
5-year avg
37.37M
10-year avg
20.09M
Marizyme, Inc.’s Enterprise Value is less than NRx Pharmaceuticals, Inc. (0), greater than RenovaCare, Inc. (20.89M), greater than Aerovate Therapeutics, Inc. (8.73K), less than Scopus BioPharma Inc. (48.13M), less than Magenta Therapeutics, Inc. (0), less than Allena Pharmaceuticals, Inc. (0), greater than Akari Therapeutics, Plc (-107741.00), greater than Armata Pharmaceuticals, Inc. (-114170976.00), greater than Anebulo Pharmaceuticals, Inc. (-29461000.00), less than Processa Pharmaceuticals, Inc. (26.33M), less than Inhibikase Therapeutics, Inc. (204.77M), less than Sio Gene Therapies Inc. (45.92M), greater than Kaleido Biosciences, Inc. (831.36K), less than Tempest Therapeutics, Inc. (172.46M), greater than null (-15427292.00), greater than null (4.26K), greater than null (14.13M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $14.89M | |
20.89M | $8.73K | |
8.73K | $78.52M | |
48.13M | $16.83K | |
0 | $42.44M | |
0 | $122.00 | |
-107741.00 | $29.50M | |
-114170976.00 | $85.03M | |
-29461000.00 | $49.01M | |
26.33M | $3.63M | |
204.77M | $175.37M | |
45.92M | $30.70M | |
831.36K | $4.26K | |
172.46M | $25.00M | |
-15427292.00 | $0 | |
4.26K | $0 | |
14.13M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marizyme, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Marizyme, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Marizyme, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Marizyme, Inc. (MRZM)?
What is the 3-year average Enterprise Value for Marizyme, Inc. (MRZM)?
What is the 5-year average Enterprise Value for Marizyme, Inc. (MRZM)?
How does the current Enterprise Value for Marizyme, Inc. (MRZM) compare to its historical average?